Skip to main content
. 2025 Aug 16;119:105883. doi: 10.1016/j.ebiom.2025.105883

Table 1.

Characteristics of the analytical sample (n = 3840), and by BMI category.

Characteristics Overall BMI categories
<25.0 kg/m2 25.0–29.9 kg/m2 ≥30.0 kg/m2
Sample size, n (%) 3840 (100) 1090 (28.4) 1412 (36.8) 1338 (34.8)
Follow-up time in years, mean (SD) 4.1 (0.8) 4.0 (0.9) 4.2 (0.7) 4.2 (0.7)
Sociodemography
 Baseline age in years, mean (SD) 69.9 (9.6) 72.6 (10.3) 70.4 (9.6) 67.3 (8.3)
 Females, n (%) 2234 (58.2) 703 (64.5) 722 (51.1) 809 (60.5)
 Education (High school grad and below), n (%) 1879 (48.9) 495 (45.4) 697 (49.4) 687 (51.3)
 Smoking status in 2016, n (%)
 Never smokers 1687 (43.9) 460 (42.2) 634 (44.9) 593 (44.3)
 Ever smokers 1710 (44.5) 473 (43.4) 616 (43.6) 621 (46.4)
 Current smokers 443 (11.5) 157 (14.4) 162 (11.5) 124 (9.3)
 Ethnicity/race, n (%)
 White/Caucasian 2891 (75.3) 892 (81.8) 1072 (75.9) 927 (69.3)
 Black/African American 647 (16.8) 132 (12.1) 211 (14.9) 304 (22.7)
 Other 302 (7.9) 66 (6.1) 129 (9.1) 107 (8.0)
 Unhealthy alcohol use in 2016, n (%) 247 (6.4) 64 (5.9) 102 (7.2) 81 (6.1)
 Age in 2014 in years, mean (SD) 67.8 (9.7) 70.3 (10.3) 68.3 (9.6) 65.1 (8.4)
 Smoking status in 2014, n (%)
 Never smokers 1650 (43.8) 451 (41.8) 619 (44.9) 580 (44.2)
 Ever smokers 1645 (43.6) 455 (42.2) 590 (42.8) 600 (45.7)
 Current smokers 476 (12.6) 173 (16.0) 171 (12.4) 132 (10.1)
Metabolic measures
 BMI in kg/m2, mean (SD) 28.7 (6.1) 22.4 (2.1) 27.3 (1.4) 35.3 (5.0)
 Hypertension, n (%) 2440 (63.6) 558 (51.2) 879 (62.3) 1003 (75.0)
 Hyperglycemia, n (%) 1752 (45.6) 327 (30.0) 642 (45.5) 783 (58.5)
 Hypertriglyceridemia, n (%) 1146 (29.9) 188 (17.3) 439 (31.1) 519 (38.8)
 Low HDL, n (%) 1010 (26.3) 154 (14.1) 382 (27.1) 474 (35.4)
 N of metabolic deficiencies, mean (SD) 1.7 (1.2) 1.1 (1.0) 1.7 (1.1) 2.1 (1.1)
 Metabolically unhealthy, n (%) 3177 (82.7) 751 (68.9) 1191 (84.3) 1235 (92.3)
 Metabolically unhealthy—less strict, N (%) 1973 (51.4) 344 (31.6) 727 (51.5) 902 (67.4)
 BMI in 2014 in kg/m2, mean (SD) 28.9 (6.23) 23.0 (2.7) 27.5 (2.4) 35.1 (5.5)
 Metabolically unhealthy in 2014, n (%) 3060 (81.1) 776 (71.9) 1115 (80.8) 1169 (89.1)
Epigentic age acceleration
 Horvath age acceleration-I, mean (SD) 0.0 (6.5) −0.1 (6.5) −0.2 (6.4) 0.3 (6.5)
 Horvath age acceleration-II, mean (SD) 0.0 (4.4) −0.3 (4.5) −0.1 (4.5) 0.3 (4.3)
 Hannum age acceleration, mean (SD) 0.0 (5.3) −0.2 (5.5) −0.2 (5.2) 0.3 (5.2)
 PhenoAge acceleration, mean (SD) 0.0 (6.9) −0.3 (7.2) −0.4 (6.8) 0.7 (6.6)
 GrimAge acceleration, mean (SD) 0.0 (4.8) −0.2 (5.2) −0.1 (4.9) 0.3 (4.3)
 DunedinPACE, mean (SD) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1)
Comorbididities
 History of cancer diagnosis, n (%) 643 (16.8) 198 (18.2) 244 (17.3) 201 (15.0)
 History of lung disease diagnosis, n (%) 483 (12.6) 152 (13.9) 144 (10.2) 187 (14.0)
 History of cardiovascular disease diagnosis, n (%) 1084 (28.3) 312 (28.6) 360 (25.5) 412 (30.9)
Vital Status in 2020
 Deceased, n (%) 176 (16.1) 133 (9.4) 114 (8.5)

Participants were categorised BMI < 25.0 kg/m2, 25.0–29.9 kg/m2, and ≥30.0 kg/m2.

BMI—body mass index, HDL—high-density lipoproteins cholesterol, kg/m2—kilograms per square metre, n—number, SD—standard deviation.